Page last updated: 2024-10-20

pyridoxine 5-phosphate and Metabolic Diseases

pyridoxine 5-phosphate has been researched along with Metabolic Diseases in 1 studies

pyridoxine 5-phosphate: RN given refers to parent cpd

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Barile, A1
Mills, P1
di Salvo, ML1
Graziani, C1
Bunik, V1
Clayton, P1
Contestabile, R1
Tramonti, A1

Other Studies

1 other study available for pyridoxine 5-phosphate and Metabolic Diseases

ArticleYear
Characterization of Novel Pathogenic Variants Causing Pyridox(am)ine 5'-Phosphate Oxidase-Dependent Epilepsy.
    International journal of molecular sciences, 2021, Nov-06, Volume: 22, Issue:21

    Topics: Brain Diseases, Metabolic; Epilepsy; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Metabolic Dis

2021